Cytochrome P450 1B1 contributes to angiotensin II-induced hypertension and associated pathophysiology.
about
Estrogen metabolism by cytochrome P450 1B1 modulates the hypertensive effect of angiotensin II in female miceiPLA2β overexpression in smooth muscle exacerbates angiotensin II-induced hypertension and vascular remodeling.Cytochrome P450 family 1 inhibitors and structure-activity relationships.Cytochrome P450 1B1 contributes to increased blood pressure and cardiovascular and renal dysfunction in spontaneously hypertensive ratsDisruption of the cytochrome P-450 1B1 gene exacerbates renal dysfunction and damage associated with angiotensin II-induced hypertension in female mice.6β-hydroxytestosterone, a cytochrome P450 1B1 metabolite of testosterone, contributes to angiotensin II-induced hypertension and its pathogenesis in male mice.Cytochrome P450 1B1 contributes to renal dysfunction and damage caused by angiotensin II in mice.Involvement of cytochrome P-450 1B1 in renal dysfunction, injury, and inflammation associated with angiotensin II-induced hypertension in rats.Contribution of cytochrome P450 1B1 to hypertension and associated pathophysiology: a novel target for antihypertensive agents.Cytochrome P450 1B1 Contributes to the Development of Atherosclerosis and Hypertension in Apolipoprotein E-Deficient Mice.Elevated blood pressure in cytochrome P4501A1 knockout mice is associated with reduced vasodilation to omega-3 polyunsaturated fatty acidsCytochrome P450 1B1 gene disruption minimizes deoxycorticosterone acetate-salt-induced hypertension and associated cardiac dysfunction and renal damage in mice.Soluble epoxide hydrolase inhibitor, TUPS, protects against isoprenaline-induced cardiac hypertrophy.Dexfenfluramine and the oestrogen-metabolizing enzyme CYP1B1 in the development of pulmonary arterial hypertensionRole of cytochrome P450-mediated arachidonic acid metabolites in the pathogenesis of cardiac hypertrophy.Cytochrome P450 and ischemic heart disease: current concepts and future directions.The role of mid-chain hydroxyeicosatetraenoic acids in the pathogenesis of hypertension and cardiac hypertrophy.Flavonoids and Naphthoflavonoids: Wider Roles in the Modulation of Cytochrome P450 Family 1 Enzymes.Potential role of CYP1B1 in the development and treatment of metabolic diseases.Cytochrome P450 1B1 Contributes to the Development of Angiotensin II-Induced Aortic Aneurysm in Male Apoe(-/-) Mice.Deletion of DGCR8 in VSMCs of adult mice results in loss of vascular reactivity, reduced blood pressure and neointima formation.Identification of CYP1B1-specific candidate inhibitors using combination of in silico screening, integrated knowledge-based filtering, and molecular dynamics simulations.Differential effects of long-term slow-pressor and subpressor angiotensin II on contractile and relaxant reactivity of resistance versus conductance arteries.
P2860
Q33787147-6687515E-8218-402C-9D5B-F4CD59F05110Q34171442-6966AEB9-B312-46CC-A8D0-F4EC1D584926Q34436975-F8AF7099-C461-40C7-A7C4-E14938628999Q35105331-A4437612-16E8-4162-A6BA-5DC8A3CB6406Q35573285-E317C34F-E38C-4E8D-B3C5-48BFD5491688Q35611363-109354D3-B7CA-4B65-98D2-44EA76BF0A05Q35707118-AFEB5BEF-9B44-49CA-9E73-B97022C55902Q35787438-993C4B60-AD80-465F-ABE1-93F5ECFAA745Q35919773-812F1BF1-24C8-40F8-B300-E24C71E0E21BQ36354759-82B77897-1B0A-4337-9836-7357AF98A68FQ36388072-2D336CBD-4549-4B5F-8E40-CB9D0D10ADBCQ36403672-DD85C700-6DCD-4387-B5C7-EB238C9A0172Q36756985-B273C1F7-6B68-43C0-A7DA-57796E201289Q36943390-67705993-5B9D-41F9-8B10-CA6E6DFA19F9Q38100223-F9839B19-6BFB-4D9B-B26F-BE0F5A9AF8B0Q38166022-3A35357D-C489-402E-B43C-1124580597ECQ38622658-EA9F9C7C-FC72-43ED-A6DC-4172117ABA64Q38934642-FC40F2A9-27FC-4B95-B0B5-C2883A32C308Q39189895-B46CF2AC-F737-4F80-AC23-CED562E92991Q41817139-8A01E4D8-EA2B-4DD5-8B4D-805C7AF28B54Q49232259-27864069-EA3F-40AF-A203-39686B1A7A3AQ51292454-9F76B1D8-38C8-4671-8DCD-331B179CD07AQ52674620-3AC4B8FA-15BA-4672-8BA3-23289A64D9F4
P2860
Cytochrome P450 1B1 contributes to angiotensin II-induced hypertension and associated pathophysiology.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Cytochrome P450 1B1 contribute ...... nd associated pathophysiology.
@ast
Cytochrome P450 1B1 contribute ...... nd associated pathophysiology.
@en
Cytochrome P450 1B1 contribute ...... nd associated pathophysiology.
@nl
type
label
Cytochrome P450 1B1 contribute ...... nd associated pathophysiology.
@ast
Cytochrome P450 1B1 contribute ...... nd associated pathophysiology.
@en
Cytochrome P450 1B1 contribute ...... nd associated pathophysiology.
@nl
prefLabel
Cytochrome P450 1B1 contribute ...... nd associated pathophysiology.
@ast
Cytochrome P450 1B1 contribute ...... nd associated pathophysiology.
@en
Cytochrome P450 1B1 contribute ...... nd associated pathophysiology.
@nl
P2093
P2860
P1433
P1476
Cytochrome P450 1B1 contribute ...... nd associated pathophysiology.
@en
P2093
Anne M Estes
Brett L Jennings
Frank J Gonzalez
Kafait U Malik
Nasreen Farjana
Seyhan Sahan-Firat
Xiao R Fang
P2860
P304
P356
10.1161/HYPERTENSIONAHA.110.154518
P407
P577
2010-08-30T00:00:00Z